Microbiological screening for methicillin-resistant Staphylococcus aureus (MRSA) is used to test colonization in specific population groups (nursing staff, patients with specific diseases, etc.).
Methicillin-resistant Staphylococcus aureus (MRSA) is a strain of Staphylococcus aureus that is resistant to methicillin, an antibiotic commonly used to treat staphylococcal infections. MRSA strains are mainly in hospitals and are responsible for increasing the length of stay in intensive care units. The mortality rate is high in graft patients infected with MRSA strains after vascular surgery. MRSA strains that are found outside of hospitals (in the community) are highly virulent, grow faster, and are genetically different from hospital strains. Community strains of MRSA can cause necrotizing skin infections and necrotizing pneumonia that can be fatal within 24 hours of onset. Both strains of MRSA are spread by contact. MRSA strains are also considered resistant to all cephalosporins and imipenem. Vancomycin is used to treat the strains.
This test is not used for the laboratory diagnosis of MRSA infection.
Laboratory test results are the most important parameter for the diagnosis and monitoring of all pathological conditions. 70%-80% of diagnostic decisions are based on laboratory tests. The correct interpretation of laboratory results allows a doctor to distinguish "healthy" from "diseased".
Laboratory test results should not be interpreted from the numerical result of a single analysis. Test results should be interpreted in relation to each individual case and family history, clinical findings, and the results of other laboratory tests and information. Your personal physician should explain the importance of your test results.
At Diagnostiki Athinon we answer any questions you may have about the test you perform in our laboratory and we contact your doctor to get the best possible medical care.